tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Stock Investors

280 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RLAY
On average, investors allocate 1.74% of their portfolios to RLAY
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RLAY

1.3%
Last 7
Days
7.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RLAY, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RLAY Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.77%
$7.79
Increased
1.94%
$7.03
Opened
1.34%
$9.37
Increased
2.01%
$8.30
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in RLAY in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RLAY Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.19%
-0.88%
-3.40%
36.58B
Consumer Cyclical
GE Aerospace
5.53%
+0.62%
+6.08%
170.19B
Industrials
Trade Desk
4.73%
-1.09%
-3.07%
39.18B
Technology
Block
4.49%
-1.09%
-7.20%
45.26B
Technology
Merck & Company
4.12%
-0.11%
-0.79%
317.52B
Healthcare
ServiceNow
4.01%
-0.30%
-0.53%
150.97B
Technology
ChargePoint Holdings
3.92%
-0.98%
-7.42%
592.70M
Consumer Cyclical
Riot Platforms
4.74%
-1.51%
-0.24%
2.02B
Financial
Coherus Biosciences
2.65%
-1.28%
-8.31%
244.02M
Healthcare
Salesforce
4.94%
+1.52%
+0.22%
268.03B
Technology
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

RLAY Investor Analysis

RLAY investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.7%
of RLAY holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
RLAY investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.6%
of RLAY holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
RLAY investors over 55

Over 55

4.9%
Last 30 days
Holdings Change
43.6%
of RLAY holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of RLAY stock investors
See who invests in RLAY according to age group and performance.

FAQ

How many retail Investors hold RLAY?
<0.1% of TipRanks' retail investors hold RLAY in their portfolios.
    What is RLAY Investor Sentiment?
    RLAY’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RLAY in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of RLAY in the last 7 days.
        What percentage of retail investors changed their holding of RLAY in the last 30 days?
        ▼ 7.8% of TipRanks' retail investors changed their holding of RLAY in the last 30 days.
          What is the average age of retail investors who hold RLAY?
          The average age of RLAY Holders is over 55.
            What other stocks have RLAY investors also bought?
            RLAY Investors also bought DKNG, GE, TTD, SQ, MRK, NOW, CHPT, RIOT, CHRS, CRM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis